Xylocaine® with Epinephrine (1%) MDV (25/Pack)

Xylocaine®
(lidocaine HCl and epinephrine Injection, USP)
For Infiltration and Nerve Block

For full product information and safety data, please visit the website of this product's manufacturer here.

Xylocaine (lidocaine HCl) Injections are sterile, nonpyrogenic, aqueous solutions that contain a local anesthetic agent with or without epi- nephrine and are administered parenterally by injection. See INDICATIONS AND USAGE section for specific uses.

Dosage forms listed as Xylocaine-MPF indi- cate single dose solutions that are Methyl Paraben Free (MPF).

• Xylocaine MPF is a sterile, nonpyrogenic, isotonic solution containing sodium chloride.
• Xylocaine in multiple dose vials: Each mL also contains 1 mg methylparaben as antiseptic pre- servative. The pH of these solutions is adjusted to approximately 6.5 (5.0 to 7.0) with sodium
  hydroxide and/or hydrochloric acid.
• Xylocaine MPF with Epinephrine is a sterile, nonpyrogenic, isotonic solution containing sodium chloride. Each mL contains lidocaine hydrochloride and epinephrine, with 0.5 mg sodium metabisulfite as an antioxidant and 0.2 mg citric acid as a stabilizer.
• Xylocaine with Epinephrine in multiple dose vials: Each mL also contains 1 mg methylparaben as antiseptic preservative. The pH of these solutions is adjusted to approximately 4.5 (3.3 to 5.5) with sodium hydroxide and/or hydrochloric acid. Filled under nitrogen.

Mechanism of Action
Lidocaine HCl stabilizes the neuronal mem- brane by inhibiting the ionic fluxes required for the initiation and conduction of impulses
thereby effecting local anesthetic action.

INDICATIONS AND USAGE:
Xylocaine (lidocaine HCl) Injections are indi- cated for production of local or regional anes- thesia by infiltration techniques such as per- cutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed.

CONTRAINDICATIONS:
Lidocaine HCl is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.

WARNINGS:
XYLOCAINE INJECTIONS FOR INFILTRATION AND NERVE BLOCK SHOULD BE EMPLOYED ONLY BY CLINICIANS WHO ARE WELL VERSED IN DIAGNOSIS AND MANAGEMENT OF DOSE-RELATED TOXICITY AND OTHER ACUTE EMERGENCIES THAT MIGHT ARISE FROM THE BLOCK TO BE EMPLOYED AND THEN ONLY AFTER ENSURING THE IMMEDIATE AVAILABILITY OF OXYGEN, OTHER RESUSCITATIVE DRUGS, CARDIOPULMONARY EQUIPMENT AND THE PERSONNEL NEEDED FOR PROPER MANAGEMENT OF TOXIC REACTIONS AND RELATED EMERGENCIES (see also ADVERSE REACTIONS and PRECAUTIONS). DELAY IN PROPER MANAGEMENT OF DOSE-RELATED TOXIC- ITY, UNDERVENTILATION FROM ANY CAUSE AND/OR ALTERED SENSITIVITY MAY LEAD TO THE DEVELOPMENT OF ACIDOSIS, CARDIAC ARREST AND, POSSIBLY, DEATH.